Addiction Treatment Program Dartmouth Hitchcock Hospital
-
Services:
- Treatment for other addiction disorder
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- The Joint Commission
- Hospital licensing authority
- State Substance use treatment agency
- State mental health department
- Outpatient detoxification
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- Intensive outpatient treatment
- Federal, or any government funding for substance use treatment programs
- Federal military insurance (e.g., TRICARE)
- Cash or self-payment
- Medicaid
- SAMHSA funding/block grants
- Private health insurance
- Medicare
- State-financed health insurance plan other than Medicaid
- Hepatitis A (HAV) vaccination
- Female
- Male
- Substance use treatment
- Detoxification
- Case management service
- Mental health services
- Transportation assistance
- Integrated primary care services
- Child care for clients’ children
- Social skills development
- Opioids detoxification
- Medication routinely used during detoxification
- Benzodiazepines Detoxification
- Alcohol Detoxification
- Drug or alcohol urine screening
- Breathalyzer or blood alcohol testing
- Pregnant/postpartum women
- Adult women
- Recovery coach
- Housing services
- Assistance with obtaining social services
- Self-help groups
- Mentoring/peer support
- Aftercare/continuing care
- Outcome follow-up after discharge
- Naloxone and overdose education
- Discharge Planning
- Vaping permitted in designated area
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Screening for mental disorders
- Interim services for clients
- Comprehensive mental health assessment
- Screening for tobacco use
- Screening for substance use
- Comprehensive substance use assessment
- General Hospital (including VA hospital)
- Prescribes buprenorphine
- Prescribes naltrexone
- Medication for mental disorders
- Disulfiram
- Naltrexone (oral)
- Naltrexone (extended-release, injectable)
- Buprenorphine without naloxone
- Acamprosate (CampralĀ®)
- Non-nicotine smoking/tobacco cessation
- Buprenorphine (extended-release, injectable)
- Buprenorphine with naloxone
- Nicotine replacement
- Clonidine
- Sign language services for the deaf and hard of hearing
- Cognitive behavioral therapy
- Brief intervention
- Relapse prevention
- Trauma-related counseling
- Telemedicine/telehealth therapy
- Motivational interviewing
- Substance use disorder counseling
- Hepatitis education, counseling, or support
- Family counseling
- Substance use disorder education
- HIV or AIDS education, counseling, or support
- Smoking/vaping/tobacco cessation counseling
- Individual counseling
- Marital/couples counseling
- Group counseling
- Health education services other than HIV/AIDS or hepatitis
- Private non-profit organization
- Smoking permitted in designated area
- Adults
- Young Adults
- Other contracted prescribing entity
- No formal relationship with prescribing entity
- In-network prescribing entity
Other Services
Type of Alcohol Use Disorder Treatment
License/Certification/Accreditation
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Payment/Insurance/Funding Accepted
Medical Services
Gender Accepted
Type of Care
Ancillary Services
Detoxification (medical withdrawal) Services
Testing
Special Programs/Groups Offered
Recovery Support Services
Transitional Services
Facility Vaping Policy
Opioid Medications used in Treatment
Assessment/Pre-treatment
Hospitals
Type of Opioid Treatment
Pharmacotherapies
Language Services
Treatment Approaches
Education and Counseling Services
Facility Operation (e.g., Private, Public)
Facility Smoking Policy
Age Groups Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment